Summary:
Clinical Outcomes study to compar the effects of Fluticasone furoate/vilanterol inhalation powder 100/25 MCG with Placebo on survival in subjects with moderate chronic obstructive pulmonary disease (COPD) and a history of or at increased risk for cardiovascular disease.
Qualified Participants Must:
• Be at least 40 years of age
•
Have been diagnosed with moderate COPD
•
Have a history of heart attack or stroke
OR
•
Be 60 years old and diagnosed with at least 2 of the following:
• High Cholesterol
• High blood pressure
• Type II Diabetes
• Peripheral vascular disease
Qualified Participants May Receive:
Study medication, study related office visits, study related laboratory work, study related procedures
and compensation for time and travel.